Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Treatment Patterns and Effectiveness Among Patients With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

NCT07386847 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07386847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07386847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Treatment Patterns and Effectiveness Among Patients With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
February 12, 2026
Completion date
March 30, 2026
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced or metastatic urothelial carcinoma, metastatic urothelial carcinoma, urothelial cancer, urothelial carcinoma